ANZICS CTG Endorsed Study
TARGET Point Prevalence Study – New Zealand OR Nutrition prescription in Australian and New Zealand intensive care units: A point prevalence audit – Australia
Study Description
The Augmented versus Routine approach to Giving Energy Trial (TARGET) was a 4000-patient randomised controlled, multicentre trial comparing augmented enteral energy delivery to standard care on 90-day survival. TARGET completed recruitment in November 2017. In order to evaluate the influence TARGET has had on current practice and may have on future practice, an understanding of current nutrition practices in Australian and New Zealand intensive care units (ICUs) must be obtained. Data on protein prescription will also guide a Phase III trial on protein delivery in critically ill adults.
This is a prospective, observational, multicentre, single-day, point-prevalence study. The objective is to determine common nutrition (energy and protein) prescriptions across Australia and New Zealand ICUs.
Management Committee
A/Prof Lee-anne Chapple (PI), Dr Anneleen Neuts, Prof Marianne Chapman, Prof Sandra Peake, Stephanie O’Connor (PM [AUS]), Patricia Williams, Sally Hurford, A/ Prof Andrew Davies, Donna Goldsmith, Sue Huckson, Ms Lorraine Little (PM-NZ), A/Prof John Moran
Administering Institution
Central Adelaide Local Health Network
Sample Size
600 patients
Funding
NHMRC
Reference
CTG1718-09
Contact
Lee-anne Chapple (email)
Stephanie O’Connor (email)